Skip Navigation LinksHome > July 2008 - Volume 27 - Issue 7 > Efficacy of Pentavalent Human-Bovine (WC3) Reassortant Rotav...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0b013e318168d29e
Brief Reports

Efficacy of Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine Based on Breastfeeding Frequency

Goveia, Michelle G. MD, MPH; DiNubile, Mark J. MD; Dallas, Michael J. PhD; Heaton, Penny M. MD; Kuter, Barbara J. PhD, MPH; for the REST Study Team

Collapse Box

Abstract

The efficacy of a live, oral, pentavalent rotavirus vaccine against G1-4 rotavirus gastroenteritis (RVGE) was retrospectively assessed based on breastfeeding frequency among 5098 infants in a placebo-controlled trial. The efficacy against any RVGE severity for infants never breastfed, sometimes breastfed, or exclusively breastfed was 68.3%, 82.2%, and 68.0%, respectively. The efficacy against severe RVGE was 100%, 95.4%, and 100%, respectively. Breastfeeding did not seem to adversely impact the efficacy of pentavalent rotavirus vaccine.

© 2008 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.